Synthesis of Planar Chiral Carbazole Derivatives Bearing a [2.2]Paracyclophane Skeleton
0.401 mmol) in AcOH (4 mL) for 8 h. Purification by column
1H), 6.52 (dd, J=7.9 and 2.0 Hz, 1H), 6.37 (dd, J=7.9 and
chromatography (pentane/Et2O=9:1) provided the title com-
pound as a white solid (75 mg, 62%): m.p. 239–2418C; H NMR
2.0 Hz, 1H), 5.94 (dd, J=7.7 and 2.0 Hz, 1H), 5.29 (dd, J=7.7
and 2.0 Hz, 1H), 3.95–3.88 (m, 1H), 3.37–3.26 (m, 1H), 3.19–2.91
(m, 6H); 13C NMR (75 MHz, CDCl3): d=157.6 (d, JCF =233 Hz),
141.1, 137.8, 137.3, 135.8, 135.1 (2C), 132.1, 131.5, 126.4, 126.3,
125.4 (d, JCF =10 Hz), 125.2 (d, JCF =5 Hz), 124.5, 122.4, 112.7 (d,
1
(400 MHz, CDCl3): d=8.06 (d, J=8.0 Hz, 1H), 7.87 (br s, 1H),
7.46 (d, J=8.0 Hz, 1H), 7.40 (dt, J=7.6 and 1.1 Hz, 1H), 7.28–
7.24 (m, 1H), 6.63 (d, J=7.4 Hz, 1H), 6.56 (d, J=7.4 Hz, 1H),
6.50 (dd, J=7.9 and 1.9 Hz, 1H), 6.36 (dd, J=7.7 and 1.9 Hz,
1H), 5.94 (dd, J=7.7 and 1.9 Hz, 1H), 5.23 (dd, J=7.7 and
1.9 Hz, 1H), 4.03–3.98 (m, 1H), 3.40–3.31 (m, 1H), 3.16–2.91 (m,
6H); 13C NMR (75 MHz, CDCl3): d=140.0, 138.8, 137.9, 137.3,
135.7, 132.0, 131.5, 131.0, 126.4, 126.3, 125.4, 125.3, 124.8, 124.5,
122.4, 122.2, 119.6, 110.6, 33.9, 33.7, 33.2, 31.1; IR (ATR): n˜ =
3392, 2924, 1592, 1572, 1499, 1456, 1394, 1322, 1299, 1247, 1026,
905, 871, 805, 747 cmÀ1; MS (EI): m/z (%)=297 ([M]+, 39), 193
(100), 192 (11), 165 (4), 149 (4), 104 (2); HRMS (EI) calcd for
C22H19N: 297.1512; found: 297.1510 [M]+.
J
CF =26 Hz), 111.1 (d, JCF =10 Hz), 107.7 (d, JCF =24 Hz), 33.8,
33.5, 33.2, 31.0; 19F NMR (282 MHz): d=À124.2; IR (ATR): n˜ =
3397, 2925, 1581, 1477, 1388, 1309, 1275, 1247, 1176, 1021, 961,
909, 862, 803, 731 cmÀ1; MS (EI): m/z (%)=315 ([M]+, 37), 211
(100), 210 (12), 183 (5), 157 (5), 104 (9); HRMS (ESI) calcd for
C22H19FN: 316.1496; found: 316.1498 [M+H]+.
[2]Paracyclo[2]6-trifluoromethyl(1,4)carbazolophane (2e): The
title compound was prepared according to GP2 using Pd(OAc)2
(18 mg, 0.080 mmol), PivOH (25 mg, 0.24 mmol) and amine 5e
(147 mg, 0.400 mmol) in AcOH (4 mL) for 8 h. The product was
purified by column chromatography (gradient pentane/Et2O=
4:1 to 7:3) providing the title compound as a light yellow solid
[2]Paracyclo[2]6-methyl(1,4)carbazolophane (2b): The title com-
pound was prepared according to GP2 using Pd(OAc)2 (18 mg,
0.080 mmol), PivOH (25 mg, 0.24 mmol) and amine 5b (126 mg,
0.402 mmol) in AcOH (4 mL) for 8 h. The product was purified
by column chromatography (pentane/Et2O=9:1) providing the
title compound as a light yellow solid (47 mg, 38%): m.p. 208–
1
(32 mg, 22%): m.p. 189–1918C; H NMR (600 MHz, CDCl3): d=
8.32 (s, 1H), 8.03 (br s, 1H), 7.66 (d, J=8.4 Hz, 1H), 7.52 (d, J=
8.9 Hz, 1H), 6.70 (d, J=7.4 Hz, 1H), 6.64 (d, J=7.4 Hz, 1H),
6.53 (dd, J=7.7 and 1.8 Hz, 1H), 6.39 (dd, J=7.7 and 1.8 Hz,
1H), 5.92 (dd, J=7.7 and 1.8 Hz, 1H), 5.22 (dd, J=7.7 and
2.0 Hz, 1H), 4.02–3.98 (m, 1H), 3.36–3.30 (m, 1H), 3.20–3.00 (m,
5H), 2.96–2.91 (m 1H); 13C NMR (150 MHz, CDCl3): d=140.6,
140.2, 137.8, 137.3, 136.0, 132.2, 131.9, 131.7, 127.3, 126.3, 125.4
(q, JCF =271 Hz), 125.0, 124.7, 124.6, 122.5, 121.9 (q, JCF =32 Hz)
121.9 (q, JCF =3 Hz), 119.7 (q, JCF =5 Hz), 110.7, 33.8, 33.6, 33.1,
31.0; 19F (564 MHz): d=À59.9; IR (ATR): n˜ =3390, 2929, 1623,
1
2108C; H NMR (300 MHz, CDCl3): d=7.86 (d, J=0.5 Hz, 1H),
7.75 (br s, 1H), 7.35 (d, J=8.2 Hz, 1H), 7.23 (dm, J=8.2 Hz,
1H), 6.61 (d, J=7.4 Hz, 1H), 6.56–6.50 (m, 2H), 6.37 (dd, J=7.8
and 1.9 Hz, 1H), 5.96 (dd, J=7.7 and 2.0 Hz, 1H), 5.29 (dd, J=
7.7 and 1.9 Hz, 1H), 4.05–3.98 (m, 1H), 3.38–3.26 (m, 1H), 3.17–
2.93 (m, 6H), 2.58 (s, 3H); 13C NMR (75 MHz, CDCl3): d=
140.3, 137.9, 137.3, 137.0, 135.7, 131.9, 131.4, 130.8, 128.8, 126.3,
126.2, 126.1, 125.4, 125.2, 124.5, 122.2, 122.1, 110.2, 33.9, 33.7,
33.2, 31.0, 21.3; IR (ATR): n˜ =3399, 2923, 2855, 1591, 1500, 1470,
1437, 1389, 1308, 1246, 1184, 905, 873, 797, 725 cmÀ1; MS (EI):
m/z (%)=311 ([M]+, 40), 207 (100), 206 (17), 204 (6), 191 (6),
104 (7); HRMS (ESI) calcd for C23H22N: 312.1747; found:
312.1753 [M+H]+.
1588, 1391, 1323, 1261, 1163, 1109, 1070, 886, 808, 716 cmÀ1
;
MS(EI): m/z (%)=365 ([M]+, 60), 261 (100), 191 (10), 104 (18),
78 (6); HRMS (ESI) calcd for C23H19NF3: 366.1464; found:
366.1464 [M+H]+.
[2]Paracyclo[2]7-methyl(1,4)carbazolophane (2 f): The title com-
pound was prepared according to GP2 using Pd(OAc)2 (18 mg,
0.080 mmol), PivOH (25 mg, 0.24 mmol) and amine 5 f (125 mg,
0.399 mmol) in AcOH (4 mL) for 8 h. Purification by column
[2]Paracyclo[2]6-isopropyl(1,4)carbazolophane (2c): The title
compound was prepared according to GP2 using Pd(OAc)2
(18 mg, 0.080 mmol), PivOH (25 mg, 0.24 mmol) and amine 5c
(137 mg, 0.401 mmol) in AcOH (4 mL) for 8 h. Purification by
column chromatography (gradient pentane/Et2O=9:1 to 17:3 to
4:1) provided the title compound as a white solid (51 mg, 37%):
m.p. 128–1308C; 1H NMR (300 MHz, CDCl3): d=7.92 (s, 1H),
7.74 (br s, 1H), 7.38 (d, J=8.0 Hz, 1H), 7.31 (dd, J=8.2 and
1.7 Hz, 1H), 6.63 (d, J=7.4 Hz, 1H), 6.57 (d, J=7.4 Hz, 1H),
6.53 (dd, J=7.9 and 2.0 Hz, 1H), 6.37 (dd, J=7.9 and 2.0 Hz,
1H), 5.95 (dd, J=7.7 and 2.0 Hz, 1H), 5.24 (dd, J=7.7 and
2.0 Hz, 1H), 4.09–4.02 (m, 1H), 3.37–2.91 (m, 8H), 1.43 (d, J=
6.9 Hz, 6H); 13C NMR (75 MHz, CDCl3): d=140.3, 140.3, 137.8,
137.3, 137.2, 135.5, 131.9, 131.3, 130.6, 126.2, 126.2, 125.4, 125.3,
124.4, 123.6, 122.1, 119.6, 110.3, 34.3, 33.9, 33.8, 33.2, 31.0, 24.9,
24.8; IR (ATR): n˜ =3396, 2954, 2928, 2861, 1591, 1501, 1470,
1388, 1317, 1245, 907, 876, 803, 725 cmÀ1; MS (EI): m/z (%)=
339 ([M]+, 57), 235 (100), 220 (40), 204 (11), 104 (13); HRMS
(ESI) calcd for C25H26N: 340.2060; found: 340.2064 [M+H]+.
chromatography (pentane/Et2O=9:1) followed by
a second
column chromatography (pentane/CHCl3 =3:7) provided the
title compound as a white solid (37 mg, 30%): m.p. 206–2098C;
1H NMR (300 MHz, CDCl3): d=7.93 (d, J=7.9 Hz, 1H), 7.72
(br, 1H), 7.23 (s, 1H), 7.09 (d, J=7.6 Hz, 1H), 6.60 (d, J=
7.7 Hz, 1H), 6.54 (d, J=7.7 Hz, 1H), 6.50 (dd, J=7.9 and 2.0 Hz,
1H), 6.37 (dd, J=7.9 and 2.0 Hz, 1H), 5.95 (dd, J=7.7 and
2.0 Hz, 1H), 5.28 (dd, J=7.7 and 2.0 Hz, 1H), 4.01–3.94 (m,
1H), 3.38–3.26 (m, 1H), 3.16–2.90 (m, 6H), 2.56 (s, 3H);
13C NMR (75 MHz, CDCl3): d=139.9, 139.3, 137.9, 137.2, 135.3,
134.9, 131.9, 131.4, 130.4, 126.3, 126.2, 125.5, 124.5, 123.1, 122.0,
122.0, 121.2, 110.7, 33.9, 33.6, 33.2, 31.1, 22.0; IR (ATR): n˜ =
3400, 3028, 2924, 2856, 1734, 1625, 1594, 1500, 1444, 1399, 1317,
1249, 1022, 926, 857, 800 cmÀ1; MS(EI): m/z (%)=311 ([M]+,
71), 207 (100), 206 (25), 191 (6), 104 (11); HRMS (EI) calcd for
C23H21N: 311.1669; found: 311.1668 [M]+.
[2]Paracyclo[2]8-methoxycarbonyl(1,4)carbazolophane (2g): The
title compound was prepared according to GP2 using Pd(OAc)2
(18 mg, 0.080 mmol), PivOH (25 mg, 0.24 mmol) and amine 5g
(143 mg, 0.400 mmol) in AcOH (4 mL) for 8 h. Purification by
column chromatography (pentane/Et2O=9:1) provided the title
compound as a light yellow solid (83 mg, 58%): m.p. 207–2098C;
1H NMR (300 MHz, CDCl3): d=9.88 (br s, 1H), 8.27 (d, J=
7.7 Hz, 1H), 8.09 (dd, J=7.7 and 1.2 Hz, 1H), 7.30 (t, J=7.8 Hz,
1H), 6.71 (d, J=7.7 Hz, 1H), 6.63 (d, J=7.7 Hz, 1H), 6.52 (dd,
J=7.8 and 1.9 Hz, 1H), 6.39 (dd, J=7.8 and 1.9 Hz, 1H), 5.96
[2]Paracyclo[2]6-fluoro(1,4)carbazolophane (2d): The title com-
pound was prepared according to GP2 using Pd(OAc)2 (18 mg,
0.080 mmol), PivOH (25 mg, 0.24 mmol) and amine 5d (127 mg,
0.400 mmol) in AcOH (4 mL) for 8 h. Purification by column
chromatography (gradient pentane/Et2O=9:1 to 4:1) provided
the title compound as a light yellow solid (44 mg, 35%): m.p.
181–1848C; H NMR (300 MHz, CDCl3): d=7.80 (br s, 1H), 7.73
(dd, J=9.7 and 2.5 Hz, 1H), 7.39–7.35 (m, 1H), 7.16 (td, J=9.0
and 2.5 Hz, 1H), 6.65 (d, J=7.4 Hz, 1H), 6.57 (d, J=7.4 Hz,
1
Isr. J. Chem. 2012, 52, 171 – 179
ꢀ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
177